MEF2A and diabetes mellitus: Diabetes enhanced the expression of fibrotic markers collagen I and III as compared with the control group, whereas shRNA-MEF2A transfection in diabetic mice significantly reduced collagen levels as compared with vehicle treatment (Figure 3A–3E).